FibroGen Appoints Deyaa Adib, M.D. as Chief Medical Officer
SAN FRANCISCO, March 11, 2024 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) today announced the appointment of Deyaa Adib, M.D., an executiv...
Source: businessinsider.com
Page 6 - Hematologic Malignancies News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Hematologic Malignancies. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Hematologic Malignancies Today - Breaking & Trending Today
Dr Danilov on Addressing Unmet Needs in Hematologic Malignancies
Alexey Danilov, MD, PhD, discusses unmet needs in hematologic malignancies to be discussed at the Bridging The Gaps in Hematologic Malignancies meeting.
Source: onclive.com
Dr Saeed on the Use of Pola-R-CHP in Previously Untreated DLBCL
Hayder Saeed, MD, discusses key takeaways regarding the use of polatuzumab vedotin plus R-CHP in diffuse large B-cell lymphoma.
Source: onclive.com
Dr Hamilton on HRQOL Differences With Gilteritinib vs Placebo in Post-Transplant FLT3-ITD+ AML
Betty Hamilton, MD, discusses quality of life differences between post-transplant gilteritinib vs placebo in FLT3-ITD–positive acute myeloid leukemia.
Source: onclive.com
Retrospective Analysis Shows Post-HCT Survival Benefits With Orca-T Vs PTCy in Hematologic Malignancies
In a retrospective analysis, Orca-T improved survival rates vs PTCy in patients with hematologic malignancies receiving myeloablative conditioning.
Source: onclive.com